ISSN: 2455-8702
Imaging Journal of Clinical and Medical Sciences
Clinical Image       Open Access      Peer-Reviewed

Saturated Spectroscopy and Unsaturated Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation

Alireza Heidari*

Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA
*Corresponding author: Alireza Heidari, Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA, E-mail: Scholar.Researcher.Scientist@gmail.com; Alireza.Heidari@calsu.us
Received: 11 January, 2018 | Accepted: 12 February, 2018 | Published: 15 February, 2018

Cite this as

Heidari A (2018) Saturated Spectroscopy and Unsaturated Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. Imaging J Clin Medical Sci 5(1): 001-007. DOI: 10.17352/2455-8702.000036

Image Article

In the current study, we have experimentally and comparatively investigated and compared malignant human cancer cells and tissues before and after irradiating of synchrotron radiation using Saturated Spectroscopy and Unsaturated Spectroscopy, respectively. It is clear that malignant human cancer cells and tissues have gradually transformed to benign human cancer cells and tissues under synchrotron radiation with the passage of time (Figures 1,2) [1–163]. It should be noted that malignant human cancer cells and tissues were exposed under white synchrotron radiation for 30 days. Furthermore, there is a shift of the spectrum in all of spectra after irradiating of synchrotron radiation that it is because of the malignant human cancer cells and tissues shrink post white synchrotron irradiation with the passage of time. In addition, all of the figures are related to the same human cancer cells and tissues. Moreover, in all of the figures y–axis shows intensity and also x–axis shows energy (keV).

It can be concluded that malignant human cancer cells and tissues have gradually transformed to benign human cancer cells and tissues under synchrotron radiation with the passage of time (Figures 1,2) [1–163].

  1. Bastogne T (2017) Quality-by-design of nanopharmaceuticals – a state of the art, Nanomedicine: Nanotechnology. Biology and Medicine, 2017. Link: https://goo.gl/AsXAPM
  2. Željka Vanić, Nataša Škalko-Basnet (2013) Nanopharmaceuticals for improved topical vaginal therapy: Can they deliver? European Journal of Pharmaceutical Sciences 50: 29-41. Link: https://goo.gl/YHnrKS
  3. German A. Islan, Marcela Durán, Maximiliano L. Cacicedo, Gerson Nakazato, Renata K.T. Kobayashi, Diego S.T. Martinez, Guillermo R. Castro, Nelson Durán (2017) Nanopharmaceuticals as a solution to neglected diseases: Is it possible? Acta Tropica 170: 16-42. Link: https://goo.gl/w3yud3
  4. Willie E. Bawarski, Elena Chidlowsky, Dhruba J. Bharali, Shaker A. Mousa (2008) Emerging nanopharmaceuticals, Nanomedicine: Nanotechnology. Biology and Medicine 4: 273-282. Link: https://goo.gl/ppWH2w
  5. Michael A.W. Eaton (2011) How do we develop nanopharmaceuticals under open innovation?, Nanomedicine: Nanotechnology, Biology and Medicine 7: 371-375. Link: https://goo.gl/q22oy8
  6. Kunn Hadinoto, Yue Yang (2014) Continuous and sustainable granulation of nanopharmaceuticals by spray coagulation encapsulation in alginate. International Journal of Pharmaceutics 473: 644-652. Link: https://goo.gl/GMZ8tU
  7. Sonke Svenson, Marc Wolfgang, Jungyeon Hwang, John Ryan, Scott Eliasof (2011) Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101. Journal of Controlled Release 153: 49-55. Link: https://goo.gl/yPsX1U
  8. Sosnik A (XXX) Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing Generally Recognized As Safe (GRAS) nanopharmaceuticals: A review. Advanced Drug Delivery Reviews 65: 1828-1851. Link: https://goo.gl/W9P8tn
  9. Jelena Filipović-Grčić, Aleš Mrhar, Hans Junginger (2013) Thematic Issue on Emerging nanopharmaceuticals for nonparenteral application routes, European Journal of Pharmaceutical Sciences 5: 1. Link: https://goo.gl/sQtA4P
  10. Yu H, Hadinoto K (2015) Mitigating the adverse effect of spray drying on the supersaturation generation capability of amorphous nanopharmaceutical powders. Powder Technology 277: 97-104. Link: https://goo.gl/C4cKYU
  11. S. Moein Moghimi, Z. Shadi Farhangrazi (2013) Nanomedicine and the complement paradigm, Nanomedicine: Nanotechnology. Biology and Medicine 9: 458-460. Link: https://goo.gl/1QDsXJ
  12. S. Eliasof, P.S. Ng, P. Lim Soo, J. Podobinski, R.I. Case, P. Shum, J.G. Martinez, S.R. Kabir, D. Lazarus, S. Svenson (2010) 425 Significantly enhanced therapeutic profile of docetaxel in novel nanopharmaceutical CRLX288. European Journal of Cancer Supplements. 8: 135.
  13. Concepción Domingo, Javier Saurina (2012) An overview of the analytical characterization of nanostructured drug delivery systems: Towards green and sustainable pharmaceuticals: A review. Analytica Chimica Acta 744: 8-22. Link: https://goo.gl/ZTsGLS
  14. Asmita Samadder, Suresh K. Abraham, Anisur Rahman Khuda-Bukhsh (2016) Nanopharmaceutical approach using pelargonidin towards enhancement of efficacy for prevention of alloxan-induced DNA damage in L6 cells via activation of PARP and p53. Environmental Toxicology and Pharmacology 43: 27-37. Link: https://goo.gl/95Bvwu
  15. Y. Yen, T. Synold, G.J. Weiss, T. Schluep, J. Ryan (2010) 423 Phase 1 dose escalation, safety and pharmacokinetic study of IT-101 (CRLX101), a novel nanopharmaceutical containing camptothecin, in advanced solid tumor cancer patients. European Journal of Cancer Supplements. 8: 134-135. Link: https://goo.gl/M5yzmk
  16. Intan DM. Azmi, Peter P. Wibroe, Lin-Ping Wu, Ali I. Kazem, Heinz Amenitsch, Seyed M. Moghimi, Anan Yaghmur (2016) A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies. Journal of Controlled Release 239: 1-9. Link: https://goo.gl/snzPh1
  17. Jun Li, Yujue Wang, Ruijing Liang, Xiangjie An, Ke Wang, Guanxin Shen, Yating Tu, Jintao Zhu, Juan Tao (2015) Recent advances in targeted nanoparticles drug delivery to melanoma, Nanomedicine: Nanotechnology. Biology and Medicine 11: 769-794. Link: https://goo.gl/SaZaHw
  18. Jinhua Liu, Yongxing Zhao, Qianqian Guo, Zhao Wang, Huiyuan Wang, Yongxin Yang, Yongzhuo Huang (2012) TAT-modified nanosilver for combating multidrug-resistant cancer. Biomaterials 33: 6155-6161. Link: https://goo.gl/92kY2E
  19. Cristina Gabellieri, Heico Frima (2011) Nanomedicine in the European Commission policy for nanotechnology, Nanomedicine: Nanotechnology. Biology and Medicine 7: 519-520. Link: https://goo.gl/AmiHK4
  20. Robert M. Frederickson, SM Moghimi, E Wagner, Seppo Yla-Herttuala (2016) Call for papers: Nanoparticle Development and Applications in Cellular and Molecular Therapies. Molecular Therapy 24: 1334-1335. Link: https://goo.gl/X7nPqz
  21. Mehrdad Namdari, Ali Eatemadi, Maryam Soleimaninejad, Aiyelabegan T. Hammed (2017) A brief review on the application of nanoparticle enclosed herbal medicine for the treatment of infective endocarditis. Biomedicine & Pharmacotherapy 87: 321-331. Link: https://goo.gl/Ufi6xb
  22. Tie Yi Kiew, Wean Sin Cheow, Kunn Hadinoto (2015) Preserving the supersaturation generation capability of amorphous drug-polysaccharide nanoparticle complex after freeze drying. International Journal of Pharmaceutics 484: 115-123. Link: https://goo.gl/tyK6AP
  23. S. Moein Moghimi, Peter P. Wibroe, Shen Y. Helvig, Z. Shadi Farhangrazi, A (2012) Christy Hunter, Genomic perspectives in inter-individual adverse responses following nanomedicine administration: The way forward. Advanced Drug Delivery Reviews 64: 1385-1393. Link: https://goo.gl/RE6h1D
  24. Pilar Rivera Gil, Dominik Hühn, Loretta L. del Mercato, Daniel Sasse, Wolfgang J. Parak (2010) Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. Pharmacological Research 62: 115-125. Link: https://goo.gl/bKn2uU
  25. Beverly A. Rzigalinski, Jeannine S. Strobl (2009) Cadmium-containing nanoparticles: Perspectives on pharmacology and toxicology of quantum dots. Toxicology and Applied Pharmacology 238: 280-288. Link: https://goo.gl/ZYfVUb
  26. Valerie E. Fako, Darin Y. Furgeson (2009) Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity. Advanced Drug Delivery Reviews 61: 478-486. Link: https://goo.gl/DDYYt7
  27. Vanessa Sainz, João Conniot, Ana I. Matos, Carina Peres, Eva Zupanǒiǒ, Liane Moura, Liana C. Silva, Helena F. Florindo, Rogério S. Gaspar (2015) Regulatory aspects on nanomedicines. Biochemical and Biophysical Research Communications 468: 504-510. Link: https://goo.gl/oVy5qE
  28. Ruth Duncan, María J. Vicent (2010) Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A criticaloverview of current status and future opportunities. Advanced Drug Delivery Reviews 62: 272-282. Link: https://goo.gl/rtVtcw
  29. Xing Zhou, Ling Che, Yanling Wei, Yin Dou, Sha Chen, Hongmei He, Hao Gong, Xiaohui Li, Jianxiang Zhang (2014) Facile route to versatile nanoplatforms for drug delivery by one-pot self-assembly. Acta Biomaterialia 10: 2630-2642. Link: https://goo.gl/FwuV7q
  30. Heidari A (2016),  Christopher Brown (2015) Study of Composition and Morphology of Cadmium Oxide (CdO) Nanoparticles for Eliminating Cancer Cells. Journal of Nanomedicine Research 2: 20. Link: https://goo.gl/Rtcgj9
  31. Heidari A (2016) Christopher Brown (2015) Study of Surface Morphological, Phytochemical and Structural Characteristics of Rhodium (III) Oxide (Rh2O3) Nanoparticles. International Journal of Pharmacology, Phytochemistry and Ethnomedicine 1: 15–19. Link: https://goo.gl/iBPkeH
  32. Heidari A (2016) (2016) An Experimental Biospectroscopic Study on Seminal Plasma in Determination of Semen Quality for Evaluation of Male Infertility. Int J Adv Technol 7: e007. Link: https://goo.gl/MkUy1K
  33. Heidari A (2016) (2016) Extraction and Preconcentration of N–Tolyl–Sulfonyl–Phosphoramid–Saeure–Dichlorid as an Anti–Cancer Drug from Plants: A Pharmacognosy Study. J Pharmacogn Nat Prod 2: e103. Link: https://goo.gl/bza3qy
  34. Heidari A (2016) (2016) A Thermodynamic Study on Hydration and Dehydration of DNA and RNA−Amphiphile Complexes. J Bioeng Biomed Sci S: 006. Link: https://goo.gl/2QrgAU
  35. Heidari A (2016) (2016) Computational Studies on Molecular Structures and Carbonyl and Ketene Groups’ Effects of Singlet and Triplet Energies of Azidoketene O=C=CH–NNN and Isocyanatoketene O=C=CH–N=C=O. J Appl Computat Math 5: e142. Link: https://goo.gl/mdT9c1
  36. Heidari A (2016) (2016) Study of Irradiations to Enhance the Induces the Dissociation of Hydrogen Bonds between Peptide Chains and Transition from Helix Structure to Random Coil Structure Using ATR–FTIR, Raman and 1HNMR Spectroscopies. J Biomol Res Ther 5: e146. Link: https://goo.gl/RsPMiU
  37. Heidari A (2016) Future Prospects of Point Fluorescence Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Cancer Cells. J Bioanal Biomed 8: e135.. Link: https://goo.gl/XDc9ui
  38. Heidari A (2016) A Bio–Spectroscopic Study of DNA Density and Color Role as Determining Factor for Absorbed Irradiation in Cancer Cells. Adv Cancer Prev 1: e102. Link: https://goo.gl/TCzTrd
  39. Heidari A (2016) Manufacturing Process of Solar Cells Using Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles. J Biotechnol Biomater 6: e125. Link: https://goo.gl/DCRvqm
  40. Heidari A (2016) A Novel Experimental and Computational Approach to Photobiosimulation of Telomeric DNA/RNA: A Biospectroscopic and Photobiological Study. J Res Development 4: 144. Link: https://goo.gl/z2ry2U
  41. Heidari A (2016) Biochemical and Pharmacodynamical Study of Microporous Molecularly Imprinted Polymer Selective for Vancomycin, Teicoplanin, Oritavancin, Telavancin and Dalbavancin Binding. Biochem Physiol 5: e146. Link: https://goo.gl/KKx1kT
  42. Heidari A (2016) Anti–Cancer Effect of UV Irradiation at Presence of Cadmium Oxide (CdO) Nanoparticles on DNA of Cancer Cells: A Photodynamic Therapy Study. Arch Cancer Res. 4: 1. Link: https://goo.gl/2z3q68
  43. Heidari A (2016) Biospectroscopic Study on Multi–Component Reactions (MCRs) in Two A–Type and B–Type Conformations of Nucleic Acids to Determine Ligand Binding Modes, Binding Constant and Stability of Nucleic Acids in Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes as Anti–Cancer Drugs. Arch Cancer Res. 4: 2. Link: https://goo.gl/JSYxBD
  44. Heidari A (2016) Simulation of Temperature Distribution of DNA/RNA of Human Cancer Cells Using Time– Dependent Bio–Heat Equation and Nd: YAG Lasers. Arch Cancer Res. 4: 2. Link: https://goo.gl/aayPUC
  45. Heidari A (2016) Quantitative Structure–Activity Relationship (QSAR) Approximation for Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for the Catalytic Formation of Proviral DNA from Viral RNA Using Multiple Linear and Non–Linear Correlation Approach. Ann Clin Lab Res. 4: 1. Link: https://goo.gl/Do2rkt
  46. Heidari A (2016) Biomedical Study of Cancer Cells DNA Therapy Using Laser Irradiations at Presence of Intelligent Nanoparticles. J Biomedical Sci. 5: 2. Link: https://goo.gl/5TwXwj
  47. Heidari A (2016) Measurement the Amount of Vitamin D2 (Ergocalciferol), Vitamin D3 (Cholecalciferol) and Absorbable Calcium (Ca2+), Iron (II) (Fe2+), Magnesium (Mg2+), Phosphate (PO4–) and Zinc (Zn2+) in Apricot Using High–Performance Liquid Chromatography (HPLC) and Spectroscopic Techniques. J Biom Biostat 7: 292. Link: https://goo.gl/LVNm3G
  48. Heidari A (2016) Spectroscopy and Quantum Mechanics of the Helium Dimer (He2+), Neon Dimer (Ne2+), Argon Dimer (Ar2+), Krypton Dimer (Kr2+), Xenon Dimer (Xe2+), Radon Dimer(Rn2+) and Ununoctium Dimer (Uuo2+) Molecular Cations. Chem Sci J 7: e112. Link: https://goo.gl/s4z9sH
  49. Heidari A (2016) Human Toxicity Photodynamic Therapy Studies on DNA/RNA Complexes as a Promising New Sensitizer for the Treatment of Malignant Tumors Using Bio–Spectroscopic Techniques. J Drug Metab Toxicol 7: e129. Link: https://goo.gl/Ht17U9
  50. Heidari A (2016) Novel and Stable Modifications of Intelligent Cadmium Oxide (CdO) Nanoparticles as Anti– Cancer Drug in Formation of Nucleic Acids Complexes for Human Cancer Cells’ Treatment. Biochem Pharmacol (Los Angel) 5: 207. Link: https://goo.gl/29ty6x
  51. Heidari A (2016) A Combined Computational and QM/MM Molecular Dynamics Study on Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h– BNNTs) as Hydrogen Storage. Struct Chem Crystallogr Commun 2: 1. Link: https://goo.gl/cED4tY
  52. Heidari A (2016) Pharmaceutical and Analytical Chemistry Study of Cadmium Oxide (CdO) Nanoparticles Synthesis Methods and Properties as Anti–Cancer Drug and its Effect on Human Cancer Cells. Pharm Anal Chem Open Access 2: 113. Link: https://goo.gl/XvnPvL
  53. Heidari A (2016) A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double– Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatment. Chemo Open Access 5: e129. Link: https://goo.gl/JEy2P1
  54. Heidari A (2016) Pharmacokinetics and Experimental Therapeutic Study of DNA and Other Biomolecules Using Lasers: Advantages and Applications. J Pharmacokinet Exp Ther 1: e005. Link: https://goo.gl/e2zXPS
  55. Heidari A (2016) Determination of Ratio and Stability Constant of DNA/RNA in Human Cancer Cells and Cadmium Oxide (CdO) Nanoparticles Complexes Using Analytical Electrochemical and Spectroscopic Techniques. Insights Anal Electrochem 2: 1. Link: https://goo.gl/JQQbwR
  56. Heidari A (2016) Discriminate between Antibacterial and Non–Antibacterial Drugs Artificial Neutral Networks of a Multilayer Perceptron (MLP) Type Using a Set of Topological Descriptors. J Heavy Met Toxicity Dis. 1: 2. Link: https://goo.gl/QHQiKa
  57. Heidari A (2016) Combined Theoretical and Computational Study of the Belousov–Zhabotinsky Chaotic Reaction and Curtius  Rearrangement  for               Synthesis  of  Mechlorethamine, isplatin,  Streptozotocin, Cyclophosphamide, Melphalan, Busulphan and BCNU as Anti–Cancer Drugs. Insights Med Phys. 1: 2. Link: https://goo.gl/dTKjUH
  58. Heidari A (2016) A Translational Biomedical Approach to Structural Arrangement of Amino Acids’ Complexes: A Combined Theoretical and Computational Study. Transl Biomed. 7: 2. Link: https://goo.gl/MjWihE
  59. Heidari A (2016) Ab Initio and Density Functional Theory (DFT) Studies of Dynamic NMR Shielding Tensors and Vibrational Frequencies of DNA/RNA and Cadmium Oxide (CdO) Nanoparticles Complexes in Human Cancer Cells. J Nanomedine Biotherapeutic Discov 6: e144. Link: https://goo.gl/mhKzww
  60. Heidari A (2016) Molecular Dynamics and Monte–Carlo Simulations for Replacement Sugars in Insulin Resistance, Obesity, LDL Cholesterol, Triglycerides, Metabolic Syndrome, Type 2 Diabetes and Cardiovascular Disease: A Glycobiological Study. J Glycobiol 5: e111. Link: https://goo.gl/sFRgeg
  61. Heidari A (2016) Synthesis and Study of 5–(Phenylsulfonyl) Amino–1,3,4–Thiadiazole–2–Sulfonamide as Potential Anti–Pertussis Drug Using Chromatography and Spectroscopy Techniques. Transl Med (Sunnyvale) 6: e138. Link: https://goo.gl/jWyRwD
  62. Heidari A (2016) Nitrogen, Oxygen, Phosphorus and Sulphur Heterocyclic Anti–Cancer Nano Drugs Separation in the Supercritical Fluid of Ozone (O3) Using Soave–Redlich–Kwong (SRK) and Pang–Robinson (PR) Equations. Electronic J Biol 12: 4. Link: https://goo.gl/nyytLg
  63. Heidari A (2016) An Analytical and Computational Infrared Spectroscopic Review of Vibrational Modes in Nucleic Acids. Austin J Anal Pharm Chem. 3: 1058. Link: https://goo.gl/G1k4XQ
  64. Heidari A (2016) Christopher Brown, Phase, Composition and Morphology Study and Analysis of Os–Pd/HfC Nanocomposites. Nano Res Appl. 2: 1. Link: https://goo.gl/Y3LRXc
  65. Heidari A (2016) Christopher Brown, Vibrational Spectroscopic Study of Intensities and Shifts of Symmetric Vibration Modes of Ozone Diluted by Cumene. International Journal of Advanced Chemistry 4: 5–9. Link: https://goo.gl/TQo7h5
  66. Heidari A (2016) Study of the Role of Anti–Cancer Molecules with Different Sizes for Decreasing Corresponding Bulk Tumor Multiple Organs or Tissues. Arch Can Res. 4: 2. Link: https://goo.gl/fxCbkd
  67. Heidari A (2016) Genomics and Proteomics Studies of Zolpidem, Necopidem, Alpidem, Saripidem, Miroprofen, Zolimidine, Olprinone and Abafungin as Anti–Tumor, Peptide Antibiotics, Antiviral and Central Nervous System (CNS) Drugs. J Data Mining Genomics & Proteomics 7: e125. Link: https://goo.gl/iDyoyZ
  68. Heidari A (2016) Pharmacogenomics and Pharmacoproteomics Studies of Phosphodiesterase–5 (PDE5) Inhibitors and Paclitaxel Albumin–Stabilized Nanoparticles as Sandwiched Anti–Cancer Nano Drugs between Two DNA/RNA Molecules of Human Cancer Cells. J Pharmacogenomics Pharmacoproteomics 7: e153. Link: https://goo.gl/TchN7N
  69. Heidari A (2016) Biotranslational Medical and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–DNA/RNA Straight and Cycle Chain Complexes as Potent Anti–Viral, Anti–Tumor and Anti– Microbial Drugs: A Clinical Approach. Transl Biomed. 7: 2. Link: https://goo.gl/K1HHjp
  70. Heidari A (2016) A Comparative Study on Simultaneous Determination and Separation of Adsorbed Cadmium Oxide (CdO) Nanoparticles on DNA/RNA of Human Cancer Cells Using Biospectroscopic Techniques and Dielectrophoresis (DEP) Method. Arch Can Res. 4: 2. A Comparative Study on Simultaneous Determination and Separation of Adsorbed Cadmium Oxide (CdO) Nanoparticles on DNA/RNA of Human Cancer Cells Using Biospectroscopic Techniques and Dielectrophoresis (DEP) Method. Link: https://goo.gl/2iZrTQ
  71. Heidari A (2016) Cheminformatics and System Chemistry of Cisplatin, Carboplatin, Nedaplatin, Oxaliplatin, Heptaplatin and Lobaplatin as Anti–Cancer Nano Drugs: A Combined Computational and Experimental Study. J Inform Data Min 1: 3. Link: https://goo.gl/g3KynK
  72. Heidari A (2016) Linear and Non–Linear Quantitative Structure–Anti–Cancer–Activity Relationship (QSACAR) Study of Hydrous Ruthenium (IV) Oxide (RuO2) Nanoparticles as Non–Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) and Anti–Cancer Nano Drugs. J Integr Oncol 5: e110. Link: https://goo.gl/bXjn1g
  73. Heidari A (2016) Synthesis, Characterization and Biospectroscopic Studies of Cadmium Oxide (CdO) Nanoparticles–Nucleic Acids Complexes Absence of Soluble Polymer as a Protective Agent Using Nucleic Acids Condensation and Solution Reduction Method. J Nanosci Curr Res 1: e101. Link: https://goo.gl/Wu5g6Q
  74. Heidari A (2016) Coplanarity and Collinearity of 4’–Dinonyl–2,2’–Bithiazole in One Domain of Bleomycin and Pingyangmycin to be Responsible for Binding of Cadmium Oxide (CdO) Nanoparticles to DNA/RNA Bidentate Ligands as Anti–Tumor Nano Drug. Int J Drug Dev & Res 8: 007–008. Link: https://goo.gl/1RzjNk
  75. Heidari A (2016) A Pharmacovigilance Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for the Prediction of Retention Time of Anti–Cancer Nano Drugs under Synchrotron Radiations. J Pharmacovigil 4: e161. Link: https://goo.gl/2r1qgq
  76. Heidari A (2016) Nanotechnology in Preparation of Semipermeable Polymers, J Adv Chem Eng 6: 157. Link: https://goo.gl/8XUf7J
  77. Heidari A (2016) A Gastrointestinal Study on Linear and Non–Linear Quantitative Structure (Chromatographic) Retention Relationships (QSRR) Models for Analysis 5–Aminosalicylates Nano Particles as Digestive System Nano Drugs under Synchrotron Radiations. J Gastrointest Dig Syst 6: e119. Link: https://goo.gl/vHfq9e
  78. Heidari A (2016) DNA/RNA Fragmentation and Cytolysis in Human Cancer Cells Treated with Diphthamide Nano Particles Derivatives. Biomedical Data Mining 5: e102. Link: https://goo.gl/1eDMaa
  79. Heidari A (2016) A Successful Strategy for the Prediction of Solubility in the Construction of Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under ynchrotron Radiations Using Genetic Function Approximation (GFA) Algorithm. J Mol Biol Biotechnol 1: 1. Link: https://goo.gl/mBZxyV
  80. Heidari A (2016) Computational Study on Molecular Structures of C20, C60, C240, C540, C960, C2160 and C3840 Fullerene Nano Molecules under Synchrotron Radiations Using Fuzzy Logic. J Material Sci Eng 5: 282. Link: https://goo.gl/94LHTe
  81. Heidari A (2016) Graph Theoretical Analysis of Zigzag Polyhexamethylene Biguanide, Polyhexamethylene Adipamide, Polyhexamethylene Biguanide Gauze and Polyhexamethylene Biguanide Hydrochloride (PHMB) Boron Nitride Nanotubes (BNNTs), Amorphous Boron Nitride Nanotubes (a–BNNTs) and Hexagonal Boron Nitride Nanotubes (h–BNNTs). J Appl Computat Math 5: e143. Link: https://goo.gl/DKoaDA
  82. Heidari A (2016) The Impact of High Resolution Imaging on Diagnosis. Int J Clin Med Imaging 3: 1000e101. Link: https://goo.gl/FkEjKx
  83. Heidari A (2016) A Comparative Study of Conformational Behavior of Isotretinoin (13–Cis Retinoic Acid) and Tretinoin (All–Trans Retinoic Acid (ATRA)) Nano Particles as Anti–Cancer Nano Drugs under Synchrotron Radiations Using Hartree–Fock (HF) and Density Functional Theory (DFT) Methods. Insights in Biomed 1: 2. Link: https://goo.gl/xeM1Ai
  84. Heidari A (2016) Advances in Logic, Operations and Computational Mathematics. J Appl Computat Math 5: 5. Link: https://goo.gl/xeM1Ai
  85. Heidari A (2016) Mathematical Equations in Predicting Physical Behavior. J Appl Computat Math 5: 5. Link: https://goo.gl/xTUDP3
  86. Heidari A (2016) Chemotherapy a Last Resort for Cancer Treatment. Chemo Open Access 5: 4. Link: https://goo.gl/MZh8QT
  87. Heidari A (2016) Separation and Pre–Concentration of Metal Cations–DNA/RNA Chelates Using Molecular Beam Mass Spectrometry with Tunable Vacuum Ultraviolet (VUV) Synchrotron Radiation and Various Analytical Methods. Mass Spectrom Purif Tech 2: e101. Link: https://goo.gl/JC5VdJ
  88. Heidari A (2016) Yoctosecond Quantitative Structure–Activity Relationship (QSAR) and Quantitative Structure–Property Relationship (QSPR) under Synchrotron Radiations Studies for Prediction of Solubility of Anti– Cancer Nano Drugs in Aqueous Solutions Using Genetic Function Approximation (GFA) Algorithm. Insight Pharm Res. 1: 1. Link: https://goo.gl/DuUjAQ
  89. Heidari A (2016) Cancer Risk Prediction and Assessment in Human Cells under Synchrotron Radiations Using Quantitative Structure Activity Relationship (QSAR) and Quantitative Structure Properties Relationship (QSPR) Studies. Int J Clin Med Imaging 3: 516. Link: https://goo.gl/oSiAv2
  90. Heidari A (2016) A Novel Approach to Biology. Electronic J Biol 12: 4. Link: https://goo.gl/3hry2f
  91. Heidari A (2016) Innovative Biomedical Equipment’s for Diagnosis and Treatment. J Bioengineer & Biomedical Sci 6: 2. Link: https://goo.gl/Ny5uSh  
  92. Heidari A (2016) Integrating Precision Cancer Medicine into Healthcare, Medicare Reimbursement Changes and the Practice of Oncology: Trends in Oncology Medicine and Practices. J Oncol Med & Pract 1: 2. Link: https://goo.gl/UKVU7w
  93. Heidari A (2016) Promoting Convergence in Biomedical and Biomaterials Sciences and Silk Proteins for Biomedical and Biomaterials Applications: An Introduction to Materials in Medicine and Bioengineering Perspectives. J Bioengineer Biomedical Sci 6: 3. Link: https://goo.gl/Qtiqas 
  94. Heidari A (2017) X–Ray Fluorescence and X–Ray Diffraction Analysis on Discrete Element Modeling of Nano Powder Metallurgy Processes in Optimal Container Design. J Powder Metall Min 6: 1, 2017. Link: https://goo.gl/8DQvYx
  95. Heidari A (2016) Biomolecular Spectroscopy and Dynamics of Nano–Sized Molecules and Clusters as Cross– Linking–Induced Anti–Cancer and Immune–Oncology Nano Drugs Delivery in DNA/RNA of Human Cancer Cells’ Membranes under Synchrotron Radiations: A Payload–Based Perspective. Arch Chem Res. 1: 2. Link: https://goo.gl/eL4sHx
  96. Heidari A (2017) Deficiencies in Repair of Double–Standard DNA/RNA–Binding Molecules Identified in Many Types of Solid and Liquid Tumors Oncology in Human Body for Advancing Cancer Immunotherapy Using Computer Simulations and Data Analysis. J Appl Bioinforma Comput Biol. 6: 1. Link: https://goo.gl/b8Q3BE
  97. Heidari A (2017) Electronic Coupling among the Five Nanomolecules Shuts Down Quantum Tunneling in the Presence and Absence of an Applied Magnetic Field for Indication of the Dimer or other Provide Different Influences on the Magnetic Behavior of Single Molecular Magnets (SMMs) as Qubits for Quantum Computing. Glob J Res Rev. 4: 2. Link: https://goo.gl/CaLiF4
  98. Heidari A (2017) Polymorphism in Nano–Sized Graphene Ligan Induced Transformation of Au38– xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) Nanomolecules for Synthesis of Au144– xAgx/xCux(SR)60, (SC4)60, (SC6)60, (SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60 and (SC6H13)60 Nano Clusters as Anti–Cancer Nano Drugs. J Nanomater Mol Nanotechnol, 6: 3. Link: https://goo.gl/5JHL9i
  99. Heidari A (2017) Biomedical Resource Oncology and Data Mining to Enable Resource Discovery in Medical, Medicinal, Clinical, Pharmaceutical, Chemical and Translational Research and Their Applications in Cancer Research. Int J Biomed Data Min 6: e103. Link: https://goo.gl/QWwmUo
  100. Heidari A (2017) Study of Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Olympiadane Nanomolecules as Agent for Cancer Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy under Synchrotorn Radiation. J Dev Drugs 6: e154. Link: https://goo.gl/C15fxF
  101. Heidari A (2017) A Novel Approach to Future Horizon of Top Seven Biomedical Research Topics to Watch in 2017: Alzheimer's, Ebola, Hypersomnia, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Microbiome/Antibiotic Resistance and Endovascular Stroke. J Bioengineer & Biomedical Sci 7: e127. Link: https://goo.gl/XqoYev
  102. Heidari A (2017) Opinion on Computational Fluid Dynamics (CFD) Technique. Fluid Mech Open Acc 4: 157. Link: https://goo.gl/xeRUuT  
  103. Heidari A (2017) Concurrent Diagnosis of Oncology Influence Outcomes in Emergency General Surgery for Colorectal Cancer and Multiple Sclerosis (MS) Treatment Using Magnetic Resonance Imaging (MRI) and Au329(SR)84, Au329–xAgx(SR)84, Au144(SR)60, Au 68 (SR)36 Au 30(SR)18, Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 and Au25(pMBA)18 Nano Clusters. J Surgery Emerg Med 1: 21. Link: https://goo.gl/JtGysE
  104. Heidari A (2017) Developmental Cell Biology in Adult Stem Cells Death and Autophagy to Trigger a Preventive Allergic Reaction to Common Airborne Allergens under Synchrotron Radiation Using Nanotechnology for Therapeutic Goals in Particular Allergy Shots (Immunotherapy). Cell Biol (Henderson, NV) 6: 1. Link: https://goo.gl/Sw47vN
  105. Heidari A (2017) Changing Metal Powder Characteristics for Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins Adjustment in Cancer Metastases Induced by Osteosarcoma, Chondrosarcoma, Carcinoid, Carcinoma, Ewing’s Sarcoma, Fibrosarcoma and Secondary Hematopoietic Solid or Soft Tissue Tumors. J Powder Metall Min 6: 170. Link: https://goo.gl/ocsgyx
  106. Heidari A (2016) Nanomedicine–Based Combination Anti–Cancer Therapy between Nucleic Acids and Anti– Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatment of Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti–Cancer Nano Drugs and Nucleic Acids Delivery under Synchrotron Radiation. Am J Drug Deliv 5: 2. Link: https://goo.gl/Jsrv2i
  107. Heidari A (2017) Clinical Trials of Dendritic Cell Therapies for Cancer Exposing Vulnerabilities in Human Cancer Cells’ Metabolism and Metabolomics: New Discoveries, Unique Features Inform New Therapeutic Opportunities, Biotech's Bumpy Road to the Market and Elucidating the Biochemical Programs that Support Cancer Initiation and Progression. J Biol Med Science 1: e103. Link: https://goo.gl/r6G6E9
  108. Heidari A (2017) The Design Graphene–Based Nanosheets as a New Nanomaterial in Anti–Cancer Therapy and Delivery of Chemotherapeutics and Biological Nano Drugs for Liposomal Anti–Cancer Nano Drugs and Gene Delivery. Br Biomed Bull 5: 305. Link: https://goo.gl/M645hu
  109. Heidari A (2017) Integrative Approach to Biological Networks for Emerging Roles of Proteomics, Genomics and Transcriptomics in the Discovery and Validation of Human Colorectal Cancer Biomarkers from DNA/RNA Sequencing Data under Synchrotron Radiation. Transcriptomics 5: e117. Link: https://goo.gl/FS8bg2
  110. Heidari A (2017) Elimination of the Heavy Metals Toxicity and Diseases in Disruption of Extracellular Matrix (ECM) Proteins and Cell Adhesion Intelligent Nanomolecules Adjustment in Cancer Metastases Using Metalloenzymes and under Synchrotron Radiation. Lett Health Biol Sci 2: 1-4. Link: https://goo.gl/1F7Gd1
  111. Heidari A (2017) Treatment of Breast Cancer Brain Metastases through a Targeted Nanomolecule Drug Delivery System Based on Dopamine Functionalized Multi–Wall Carbon Nanotubes (MWCNTs) Coated with Nano Graphene Oxide (GO) and Protonated Polyaniline (PANI) in Situ During the Polymerization of Aniline Autogenic Nanoparticles for the Delivery of Anti–Cancer Nano Drugs under Synchrotron Radiation. Br J Res 4: 16, 2017. Link: https://goo.gl/tf5ZKr
  112. Heidari A (2017) Sedative, Analgesic and Ultrasound–Mediated Gastrointestinal Nano Drugs Delivery for Gastrointestinal Endoscopic Procedure, Nano Drug–Induced Gastrointestinal Disorders and Nano Drug Treatment of Gastric Acidity. Res Rep Gastroenterol 1: 1. Link: https://goo.gl/BuAoGS
  113. Heidari A (2017) Synthesis, Pharmacokinetics, Pharmacodynamics, Dosing, Stability, Safety and Efficacy of Orphan Nano Drugs to TreatHigh Cholesterol and Related Conditions and to PreventCardiovascular Disease under Synchrotron Radiation. J Pharm Sci Emerg Drugs 5: 1. Link: https://goo.gl/yfH2DZ
  114. Heidari A (2017) Non–Linear Compact Proton Synchrotrons to Improve Human Cancer Cells and Tissues Treatments and Diagnostics through Particle Therapy Accelerators with Monochromatic Microbeams. J Cell Biol Mol Sci 2: 1–5. Link: https://goo.gl/XvKgF3
  115. Heidari A (2017) Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood–Brain Barrier (BBB) Translocation to Targeted Deliver Anti–Cancer Nano Drugs into the Human Brain to Treat Alzheimer’s Disease under Synchrotron Radiation. J Nanotechnol Material Sci 4: 1–5. Link: https://goo.gl/QRhY5n
  116. Ricardo Gobato, Heidari A (2017) Calculations Using Quantum Chemistry for Inorganic Molecule Simulation BeLi2SeSi. American Journal of Quantum Chemistry and Molecular Spectroscopy 2: 37–46. Link: https://goo.gl/dt1Zjc
  117. Heidari A (2017) Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Lung Cancer Translational Anti–Cancer Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations. J Med Oncol 1: 1. Link: https://goo.gl/Bkqz4B
  118. Heidari A (2017) A Modern Ethnomedicinal Technique for Transformation, Prevention and Treatment of Human Malignant Gliomas Tumors into Human Benign Gliomas Tumors under Synchrotron Radiation. Am J Ethnomed 4: 10. Link: https://goo.gl/LgtP7q
  119. Heidari A (2017) An Investigation of the Role of DNA as Molecular Computers: A Computational Study on the Hamiltonian Path Problem. International Journal of Scientific & Engineering Research, Vol. 5, Issue 1, Pages 1884–1889, 2014. Link: https://goo.gl/FstbNS
  120. Heidari A (2017) Active Targeted Nanoparticles for Anti–Cancer Nano Drugs Delivery across the Blood– Brain Barrier for Human Brain Cancer Treatment, Multiple Sclerosis (MS) and Alzheimer's Diseases Using Chemical Modifications of Anti–Cancer Nano Drugs or Drug–Nanoparticles through Zika Virus (ZIKV) Nanocarriers under Synchrotron Radiation. J Med Chem Toxicol. 2: 1–5. Link: https://goo.gl/ezGSro
  121. Heidari A (2017) Investigation of Medical, Medicinal, Clinical and Pharmaceutical Applications of Estradiol, Mestranol (Norlutin), Norethindrone (NET), Norethisterone Acetate (NETA), Norethisterone Enanthate (NETE) and Testosterone Nanoparticles as Biological Imaging, Cell Labeling, Anti–Microbial Agents and Anti–Cancer Nano Drugs in Nanomedicines Based Drug Delivery Systems for Anti–Cancer Targeting and Treatment. Parana Journal of Science and Education (PJSE) 3: 10–19.
  122. Heidari A (2017) A Comparative Computational and Experimental Study on Different Vibrational Biospectroscopy Methods, Techniques and Applications for Human Cancer Cells in Tumor Tissues Simulation, Modeling, Research, Diagnosis and Treatment. Open J Anal Bioanal Chem 1: 014–020. Link: https://goo.gl/Sbz6Zc
  123. Heidari A (2017) Combination of DNA/RNA Ligands and Linear/Non–Linear Visible–Synchrotron Radiation– Driven N–Doped Ordered Mesoporous Cadmium Oxide (CdO) Nanoparticles Photocatalysts Channels Resulted in an Interesting Synergistic Effect Enhancing Catalytic Anti–Cancer Activity. Enz Eng 6: 1. Link: https://goo.gl/hZKKRQ
  124. Heidari A (2017) Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS). Mod Appro Drug Des. 1: MADD.000504. Link: https://goo.gl/y9MM8v
  125. Heidari A (2017) Potency of Human Interferon β–1a and Human Interferon β–1b in Enzymotherapy, Immunotherapy, Chemotherapy, Radiotherapy, Hormone Therapy and Targeted Therapy of Encephalomyelitis Disseminate/Multiple Sclerosis (MS) and Hepatitis A, B, C, D, E, F and G Virus Enter and Targets Liver Cells. J Proteomics Enzymol 6: 1. Link: https://goo.gl/NwJUaa
  126. Heidari A (2017) Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti–Cancer Nanodrugs Delivery across the Blood–Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation. J Pharm Pharmaceutics 4: 1–5. Link: https://goo.gl/gViYGr
  127. Heidari A, Brown C (2017) Combinatorial Therapeutic Approaches to DNA/RNA and Benzylpenicillin (Penicillin G), Fluoxetine Hydrochloride (Prozac and Sarafem), Propofol (Diprivan), Acetylsalicylic Acid (ASA) (Aspirin), Naproxen Sodium (Aleve and Naprosyn) and Dextromethamphetamine Nanocapsules with Surface Conjugated DNA/RNA to Targeted Nano Drugs for Enhanced Anti–Cancer Efficacy and Targeted Cancer Therapy Using Nano Drugs Delivery Systems. Ann Adv Chem 1: 061–069.
  128. Heidari A (2017) Vibrational Spectroscopy of Nucleic Acids. Wahid Ali Khan (Editor), Basic Biochemistry. Austin Publishing Group (APG)/Austin Publications LLC, ISBN: 978–0–9971499–2–0, 1–18. Link: https://goo.gl/xAQYPq
  129. Heidari A (2017) High–Resolution Simulations of Human Brain Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron Radiation. J Transl Res 1: 1–3. Link: https://goo.gl/x9tfNW
  130. Heidari A (2017) Investigation of Anti–Cancer Nano Drugs’ Effects’ Trend on Human Pancreas Cancer Cells and Tissues Prevention, Diagnosis and Treatment Process under Synchrotron and X–Ray Radiations with the Passage of Time Using Mathematica. Current Trends Anal Bioanal Chem 1: 36–41. Link: https://goo.gl/bTFRFU
  131. Heidari A (2017) Pros and Cons Controversy on Molecular Imaging and Dynamics of Double–Standard DNA/RNA of Human Preserving Stem Cells–Binding Nano Molecules with Androgens/Anabolic Steroids (AAS) or Testosterone Derivatives through Tracking of Helium–4 Nucleus (Alpha Particle) Using Synchrotron Radiation. Arch Biotechnol Biomed. 1: 067–100. Link: https://goo.gl/h2W1Ky
  132. Heidari A (2017) Visualizing Metabolic Changes in Probing Human Cancer Cells and Tissues Metabolism Using Vivo 1H or Proton NMR, 13C NMR, 15N NMR and 31P NMR Spectroscopy and Self–Organizing Maps under Synchrotron Radiation. SOJ Mater Sci Eng 5: 1–6. Link: https://goo.gl/NaLrtC
  133. Heidari A (2017) Cavity Ring–Down Spectroscopy (CRDS), Circular Dichroism Spectroscopy, Cold Vapour Atomic Fluorescence Spectroscopy and Correlation Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. Enliven: Challenges Cancer Detect Ther 4: e001. Link: https://goo.gl/B7Z9mn
  134. Heidari A (2017) Laser Spectroscopy, Laser–Induced Breakdown Spectroscopy and Laser–Induced Plasma Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. Int J Hepatol Gastroenterol 3: 079–084. Link: https://goo.gl/M3qQRn
  135. Heidari A (2017) Time–Resolved Spectroscopy and Time–Stretch Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. Enliven: Pharmacovigilance and Drug Safety 4: e001. Link: https://goo.gl/PQaVPM
  136. Heidari A (2017) Overview of the Role of Vitamins in Reducing Negative Effect of Decapeptyl (Triptorelin Acetate or Pamoate Salts) on Prostate Cancer Cells and Tissues in Prostate Cancer Treatment Process through Transformation of Malignant Prostate Tumors into Benign Prostate Tumors under Synchrotron Radiation. Open J Anal Bioanal Chem 1: 021–026. Link: https://goo.gl/QCtsh1
  137. Heidari A (2017) Electron Phenomenological Spectroscopy, Electron Paramagnetic Resonance (EPR) Spectroscopy and Electron Spin Resonance (ESR) Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. Austin J Anal Pharm Chem 4: 1091. Link: https://goo.gl/2nR7FR
  138. Heidari A (2017) Therapeutic Nanomedicine Different High–Resolution Experimental Images and Computational Simulations for Human Brain Cancer Cells and Tissues Using Nanocarriers Deliver DNA/RNA to Brain Tumors under Synchrotron Radiation with the Passage of Time Using Mathematica and MATLAB. Madridge J Nano Tech Sci 2: 77–83. Link: https://goo.gl/EZy2uh
  139. Heidari A (2017) A Consensus and Prospective Study on Restoring Cadmium Oxide (CdO) Nanoparticles Sensitivity in Recurrent Ovarian Cancer by Extending the Cadmium Oxide (CdO) Nanoparticles–Free Interval Using Synchrotron Radiation Therapy as Antibody–Drug Conjugate for the Treatment of Limited–Stage Small Cell Diverse Epithelial Cancers. Cancer Clin Res Rep 1: e001.
  140. Heidari A (2017) A Novel and Modern Experimental Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White Synchrotron Radiation. Cancer Sci Res Open Access 4: 1–8. Link: https://goo.gl/3UaojE
  141. Heidari A (2017) Different High–Resolution Simulations of Medical, Medicinal, Clinical, Pharmaceutical and Therapeutics Oncology of Human Breast Cancer Translational Nano Drugs Delivery Treatment Process under Synchrotron and X–Ray Radiations. J Oral Cancer Res 1: 12–17. Link: https://goo.gl/5cFZFZ
  142. Heidari A (2017) Vibrational Decihertz (dHz), Centihertz (cHz), Millihertz (mHz), Microhertz (μHz), Nanohertz (nHz), Picohertz (pHz), Femtohertz (fHz), Attohertz (aHz), Zeptohertz (zHz) and Yoctohertz (yHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation. International Journal of Biomedicine 7: 335–340. Link: https://goo.gl/Qf6Xeb
  143. Heidari A (2017) Force Spectroscopy and Fluorescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. EC Cancer 2: 239–246. Link: https://goo.gl/m96ujT
  144. Heidari A (2017) Photoacoustic Spectroscopy, Photoemission Spectroscopy and Photothermal Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. BAOJ Cancer Res Ther 3: 045–052. Link: https://goo.gl/qDFpGv
  145. Heidari A (2017) J–Spectroscopy, Exchange Spectroscopy (EXSY), Nucle¬ar Overhauser Effect Spectroscopy (NOESY) and Total Correlation Spectroscopy (TOCSY) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation. EMS Eng Sci J 1: 006–013.
  146. Heidari A (2017) Neutron Spin Echo Spectroscopy and Spin Noise Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. Int J Biopharm Sci 1: 103–107.
  147. Heidari A (2017) Vibrational Decahertz (daHz), Hectohertz (hHz), Kilohertz (kHz), Megahertz (MHz), Gigahertz (GHz), Terahertz (THz), Petahertz (PHz), Exahertz (EHz), Zettahertz (ZHz) and Yottahertz (YHz) Imaging and Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation. Madridge J Anal Sci Instrum 2: 41–46.
  148. Heidari A (2018) Two–Dimensional Infrared Correlation Spectroscopy, Linear Two–Dimensional Infrared Spectroscopy and Non–Linear Two–Dimensional Infrared Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time. J Mater Sci Nanotechnol 6: 101. Link: https://goo.gl/GU9YtC
  149. Heidari A (2018) Fourier Transform Infrared (FTIR) Spectroscopy, Near–Infrared Spectroscopy (NIRS) and Mid–Infrared Spectroscopy (MIRS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time. Int J Nanotechnol Nanomed 3: 1– 6.
  150. Heidari A (2018) Infrared Photo Dissociation Spectroscopy and Infrared Correlation Table Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time. Austin Pharmacol Pharm 3: 1011.
  151. Heidari A (2017) Novel and Transcendental Prevention, Diagnosis and Treatment Strategies for Investigation of Interaction among Human Blood Cancer Cells, Tissues, Tumors and Metastases with Synchrotron Radiation under Anti–Cancer Nano Drugs Delivery Efficacy Using MATLAB Modeling and Simulation. Madridge J Nov Drug Res 1: 18–24.
  152. Heidari A (2018) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. Open Access J Trans Med Res 2: 00026–00032. Link: https://goo.gl/ABx21z
  153. Marcia Regina Risso Gobato Gobato, Ricardo Gobato, Heidari A (2018) Planting of Jaboticaba Trees for Landscape Repair of Degraded Area. Landscape Architecture and Regional Planning 3: 1–9. Link: https://goo.gl/9Q9mTc
  154. Heidari A (2018) Fluorescence Spectroscopy, Phosphorescence Spectroscopy and Luminescence Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation with the Passage of Time. SM J Clin. Med. Imaging 4: 1018. Link: https://goo.gl/MQrBfc
  155. Heidari A (2018) Nuclear Inelastic Scattering Spectroscopy (NISS) and Nuclear Inelastic Absorption Spectroscopy (NIAS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation. Int J Pharm Sci 2: 1–14. Link: https://goo.gl/uNtscF
  156. Heidari A (2018) X–Ray Diffraction (XRD), Powder X–Ray Diffraction (PXRD) and Energy–Dispersive X– Ray Diffraction (EDXRD) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation. J Oncol Res 2: 1–14. Link: https://goo.gl/7jvs5k
  157. Heidari A (2018) Correlation Two–Dimensional Nuclear Magnetic Reso¬nance (NMR) (2D–NMR) (COSY) Imaging and Spectrosco¬py Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation. EMS Can Sci 1: 1–001.
  158. Heidari A (2018) Thermal Spectroscopy, Photothermal Spectroscopy, Thermal Microspectroscopy, Photothermal Microspectroscopy, Thermal Macrospectroscopy and Photothermal Macrospectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under Synchrotron Radiation. SM J Biometrics Biostat 3: 1024. Link: https://goo.gl/xdXkzf
  159. Heidari A (2018) Modern and Comprehensive Experimental Biospectroscopic Comparative Study on Human Common Cancers’Cells, Tissues and Tumors before and after Synchrotron Radiation Therapy. Open Acc J Oncol Med 1. Link: https://goo.gl/gqe7eh
  160. Heidari A (2018) Pros and Cons Controversy on Heteronuclear Correlation Experiments such as Heteronuclear Single–Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation. EMS Pharma J 1: 002.
  161. Heidari A (2018) Heteronuclear Correlation Experiments such as Heteronuclear Single– Quantum Correlation Spectroscopy (HSQC), Heteronuclear Multiple–Quantum Correlation Spectroscopy (HMQC) and Heteronuclear Multiple–Bond Correlation Spectroscopy (HMBC) Comparative Study on Malignant and Benign Human Endocrinology and Thyroid Cancer Cells and Tissues under Synchrotron Radiation. J Endocrinol Thyroid Res 3: 555603. Link: https://goo.gl/5uqE6U
  162. Heidari A (2018) Nuclear Resonance Vibrational Spectroscopy (NRVS), Nuclear Inelastic Scattering Spectroscopy (NISS), Nuclear Inelastic Absorption Spectroscopy (NIAS) and Nuclear Resonant Inelastic X–Ray Scattering Spectroscopy (NRIXSS) Comparative Study on Malignant and Benign Human Cancer Cells and Tissues under Synchrotron Radiation. Int J Bioorg Chem Mol Biol 6: 1–5. Link: https://goo.gl/mn7Le4
  163. Heidari A (2018) A Novel and Modern Experimental Approach to Vibrational Circular Dichroism Spectroscopy and Video Spectroscopy Comparative Study on Malignant and Benign Human Cancer Cells and Tissues with the Passage of Time under White and Monochromatic Synchrotron Radiation. Glob J Endocrinol Metab 1: GJEM. 000514–000519. Link: https://goo.gl/Hn9UUS
© 2018 Heidari A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.